secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sagimet Biosciences Inc. (SGMT)
CIK:        0001400118
Form:       8-K
Filed at:   2025-06-10T23:59:59+00:00
Accession:  0001104659-25-058201
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sagimet amends executive severance agreements with CEO, CFO, and NEO
--------------------------------------------------------------------

- CEO David Happel gets 24 months base salary, target bonus, equity acceleration on change-in-control termination.
- CFO Thierry Chauche and NEO Eduardo Martins get 15 months severance under same conditions.
- Annual meeting elected Elizabeth Grammer and Beth Seidenberg as Class II directors; ratified Deloitte & Touche as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1400118/000110465925058201/0001104659-25-058201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1400118/000110465925058201/tm2517631d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer